Selina J Hein

6PUBLICATIONS
18CO-AUTHORS
Gene and molecular therapyCell physiologyCardiology (incl. cardiovascular diseases)Autonomic nervous systemMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 13, 2025
Profibrotic Biomarkers Correlate with Clinical Presentation and Outcome in Cardiac Transthyretin Amyloidosis.

Selina J Hein, Fabian Aus dem Siepen, Arnt V Kristen

|Oct 20, 2025
Progression of QRS duration - a potential surrogate marker of survival in ATTRwt amyloidosis patients.

Selina Hein, Fabian Aus dem Siepen, Sonja M Zierleyn

|Apr 27, 2024
Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis.

Fabian Aus dem Siepen, Selina Hein, Eva Hofmann

|Jan 22, 2021
Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis.

Selina Hein, Jennifer Furkel, Maximilian Knoll

|Dec 07, 2020
Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience.

Matthias N Ungerer, Ernst Hund, Jan C Purrucker

|Dec 19, 2019
The Zebrafish (Danio rerio) Is a Relevant Model for Studying Sex-Specific Effects of 17β-Estradiol in the Adult Heart.

Selina Hein, David Hassel, Georgios Kararigas

Pageof 1